Gender-specific differences in bladder cancer: A retrospective analysis

Gender Medicine

Volumn 5, Issue 4, 2008, Pages 385-394

  Horstmann, Marcus ^a   Witthuhn, Ralf ^b   Falk, Markus ^c   Stenzl, Arnulf ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b KLINIKUM KASSEL   (Germany)

^c Inova Q Inc   (Italy)

Author keywords

bladder cancer; epidemiology; gender differences; risk factors

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; AUSTRIA; BLADDER CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER GROWTH; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SEX RATIO; TRANSURETHRAL RESECTION; URETHRA;

ADULT; AGED; AGED, 80 AND OVER; AUSTRIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 57649199613     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genm.2008.11.002     Document Type: Article

References (28)

1. Ferlay J., Autier P., Boniol M., et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 (2007) 581-592
2. Brennan P., Bogillot O., Cordier S., et al. Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case-control studies. Int J Cancer 86 (2000) 289-294
3. Brennan P., Bogillot O., Greiser E., et al. The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control 12 (2001) 411-417
4. Samanic C., Kogevinas M., Dosemeci M., et al. Smoking and bladder cancer in Spain: Effects of tobacco type, timing, environmental tobacco smoke, and gender [published correction appears in Cancer Epidemiol Biomarkers Prev. 2006,15:1568]. Cancer Epidemiol Biomarkers Prev 15 (2006) 1348-1354
5. Kogevinas M., 't Mannetje A., Cordier S., et al. Occupation and bladder cancer among men in Western Europe. Cancer Causes Control 14 (2003) 907-914
6. Mannetje A., Kogevinas M., Chang-Claude J., et al. Occupation and bladder cancer in European women. Cancer Causes Control 10 (1999) 209-217
7. Olfert S.M., Felknor S.A., and Delclos G.L. An updated review of the literature: Risk factors for bladder cancer with focus on occupational exposures. South Med J 99 (2006) 1256-1263
8. Hayne D., Arya M., Quinn M.J., et al. Current trends in bladder cancer in England and Wales. J Urol 172 (2004) 1051-1055
9. Hartge P., Harvey E.B., Linehan W.M., et al. Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst 82 (1990) 1636-1640
10. Cantor K.P., Lynch C.F., and Johnson D. Bladder cancer, parity, and age at first birth. Cancer Causes Control 3 (1992) 57-62
11. Barbeau E.M., Leavy-Sperounis A., and Balbach E.D. Smoking, social class, and gender: What can public health learn from the tobacco industry about disparities in smoking?. Tob Control 13 (2004) 115-120
12. Andersen A., Barlow L., Engeland A., et al. Workrelated cancer in the Nordic countries. Scand J Work Environ Health 25 Suppl 2 (1999) 1-116
13. McGrath M., Michaud D.S., and De Vivo I. Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol 163 (2006) 236-244
14. Cantwell M.M., Lacey Jr. J.V., Schairer C., et al. Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study. Int J Cancer 119 (2006) 2398-2401
15. Madeb R., and Messing E.M. Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 22 (2004) 86-92
16. In: Sobin L.H., and Wittekind C.H. (Eds). TNM Classification of Malignant Tumours. 6th ed (2002), Wiley Liss, New York, NY 199-202
17. Epstein J.I., Amin M.B., Reuter V.R., Mostofi F.K., and for the Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22 (1998) 1435-1448
18. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statis 6 (1979) 65-70
19. Hayat M.J., Howlader N., Reichman M.E., and Edwards B.K. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12 (2007) 20-37
20. Kelloff G.J., Boone C.W., Malone W.F., et al. Development of chemopreventive agents for bladder cancer. J Cell Biochem 161 Suppl (1992) 1-12
21. Kiemeney L.A., Coebergh J.W., Koper N.P., et al. Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989. Eur J Cancer 30A (1994) 1134-1137
22. Mungan N.A., Aben K.K., Schoenberg M.P., et al. Gender differences in stage-adjusted bladder cancer survival. Urology 55 (2000) 876-880
23. Mungan N.A., Kiemeney L.A., van Dijck J.A., et al. Gender differences in stage distribution of bladder cancer. Urology 55 (2000) 368-371
24. Fleshner N.E., Herr H.W., Stewart A.K., et al., for the American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on bladder carcinoma. Cancer 78 (1996) 1505-1513
25. Erckert M., Stenzl A., Falk M., and Bartsch G. Incidence of urethral tumor involvement in 910 men with bladder cancer. World J Urol 14 (1996) 3-8
26. Page B.H., Levison V.B., and Curwen M.P. The site of recurrence of non-infiltrating bladder tumours. Br J Urol 50 (1978) 237-242
27. Samodai L., Kolozsy Z., Mohdcsi L., and Dauda G. Localization of primary and recurrent bladder tumors [in Hungarian]. Orv Hetil 132 (1991) 1421-1426
28. Cohen S.M., Shirai T., and Steineck G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl 205 (2000) 105-115